Who
Alireza Javadi
Chief Technical Officer
Company insider
Files Form 4 as: Chief Technical Officer, Rani Therapeutics Holdings.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $602
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 27 Mar 2026
- Last trade
- 27 Sep 2026
- Last filed
- 29 Sep 2026
Companies traded
Activity over time
1 Mar – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 Sep 2026filed 29 Sep 2026 | RANI Rani Therapeutics HoldingsBiotechnology | SEC FORM 4 Code F | $235309 at $0.7592 | filing |
| 27 Sep 2026filed 29 Sep 2026 | RANI Rani Therapeutics HoldingsBiotechnology | SEC FORM 4 Code F | $235309 at $0.76 | filing |
| 27 Jun 2026filed 21 Jul 2026 | RANI Rani Therapeutics HoldingsBiotechnology | SEC FORM 4 Code F | $229309 at $0.74 | filing |
| 27 Jun 2026filed 21 Jul 2026 | RANI Rani Therapeutics HoldingsBiotechnology | SEC FORM 4 Code F | $229309 at $0.74 | filing |
| 3 Jun 2026filed 5 Jun 2026 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —805,500 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | RANI Rani Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —805,500 at $0.00 | filing |
| 27 Mar 2026filed 21 Jul 2026 | RANI Rani Therapeutics HoldingsBiotechnology | SEC FORM 4 Sold | $301386 at $0.78 | filing |
| 27 Mar 2026filed 21 Jul 2026 | RANI Rani Therapeutics HoldingsBiotechnology | SEC FORM 4 Sold | $301386 at $0.78 | filing |
News
No headline names them, or the companies they trade most, lately.